SoftBank's PayPay prices IPO at $16 per share, filing shows-March 2024-www.financetom.com

SoftBank's PayPay prices IPO at $16 per share, filing shows

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

SoftBank's PayPay prices IPO at $16 per share, filing shows

Mar 11, 2026 6:11 PM

TOKYO, March 12 (Reuters) - Japanese digital wallet

provider PayPay, backed by SoftBank Group, has

priced its initial public offering at $16 per share, a filing

from SoftBank subsidiary LY Corp showed.

PayPay initially wanted to sell shares in a range between

$17 to $20 per share but sources told Reuters that it was likely

to be around the low end of this range as the war in the Middle

East hit markets.

Previous page： Gelteq Customer Increases Order Quantity by 50% Next page： BRIEF-Arthur J. Gallagher & Co. Acquires Hann Insurance Brokers Pty Ltd

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Gelteq Customer Increases Order Quantity by 50%

Dec 2, 2024

11:13 AM EST, 12/02/2024 (MT Newswires) -- Gelteq ( GELS ) said Monday its largest customer in the US, Healthy Extracts, has increased its order of the company's collagen and Mynus sugar blocker gels by 50%. Production of Healthy Extracts' order is already in progress, with shipments expected in January, the company said. The companies also plan to introduce new...

BRIEF-Arthur J. Gallagher & Co. Acquires Hann Insurance Brokers Pty Ltd

Dec 2, 2024

Dec 2 (Reuters) - Arthur J. Gallagher & Co. ( AJG ): * ARTHUR J. GALLAGHER & CO. ( AJG ) ACQUIRES HANN INSURANCE BROKERS PTY LTD * ARTHUR J. GALLAGHER & CO. ( AJG ) - TERMS OF THE TRANSACTION NOT DISCLOSED Source text: Further company coverage: ...

Spectral Medical Provides November Tigris Trial Update

Dec 2, 2024

11:10 AM EST, 12/02/2024 (MT Newswires) -- Spectral Medical ( EDTXF ) developing therapeutic options for sepsis and septic shock, on Monday said medical supply disruptions have impacted patient enrollment for its Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (PMX) in adults treated for endotoxemia and septic shock. The company says 136 patients...

Nisun International Has $82 Million Corn Supply Deal

Dec 2, 2024

11:09 AM EST, 12/02/2024 (MT Newswires) -- Nisun International Enterprise Development ( NISN ) has a strategic cooperation agreement with Henan Yingda Feng Agricultural Development for the annual supply of 200,000 tons of corn products valued at 600 million renminbi ($82 million). Our entry into the corn supply chain builds on our proven expertise in integrated supply chain services, highlighting...